Advanced search
Publication Cover
Leukemia & Lymphoma Volume 45, 2004 - Issue 9
Submit an article Journal homepage
38
Views
7
CrossRef citations to date
0
Altmetric
Original Article

Effectiveness of Fludarabine, Idarubicin and Cyclophosphamide (FLUIC) Combination Regimen for Young Patients with Untreated Non-Follicular Low-Grade Non-Hodgkin's Lymphoma

Pier Luigi Zinzani Institute of Hematology and Medical Oncology “Seràgnoli”, University of Bologna, Bologna, ItalyCorrespondence[email protected]
,
Alessandro Pulsoni Departments of Cellular Biotechnology and Hematology, University “La Sapienza” of Roma, Roma, Italy
,
Patrizia Gentilini Division of Oncology, Forlì Hospital, Forlì
,
Giuseppe Visani Division of Hematology, Pesaro Hospital, Pesaro, Italy
,
Alessio Perrotti Chair of Hematology, “Tor Vergata” University of Roma, Roma, Italy
,
Anna Lia Molinari Division of Hematology, Ravenna Hospital, Ravenna, Italy
,
Luciano Guardigni Division of Hematology, Cesena Hospital, Cesena, Italy
,
Monica Tani Institute of Hematology and Medical Oncology “Seràgnoli”, University of Bologna, Bologna, Italy
,
Nicoletta Villivà Departments of Cellular Biotechnology and Hematology, University “La Sapienza” of Roma, Roma, Italy
,
Vittorio Stefoni Division of Oncology, Forlì Hospital, Forlì
,
Lapo Alinari Division of Hematology, Pesaro Hospital, Pesaro, Italy
,
Maurizio Martelli Chair of Hematology, “Tor Vergata” University of Roma, Roma, Italy
,
Francesca Bonifazi Division of Hematology, Ravenna Hospital, Ravenna, Italy
,
Stefano Pileri Division of Hematology, Cesena Hospital, Cesena, Italy
,
Sante Tura Institute of Hematology and Medical Oncology “Seràgnoli”, University of Bologna, Bologna, Italy
&
Michele Baccarani Departments of Cellular Biotechnology and Hematology, University “La Sapienza” of Roma, Roma, Italy
 show all
Pages 1815-1819 | Received 26 Mar 2004, Published online: 03 Aug 2009

Citations (7)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Joaquin Martínez-López, Joaquin Martínez-López, Ana Rivero, Inmaculada Rapado, Carlos Montalbán, Jose Paz-Carreira, Miguel Canales, Rafael Martínez, Pedro Sánchez-Godoy, Alberto Fernández de Sevilla, Francisco J. Peñalver, Marcos Gonzalez, Elena Prieto, Antonio Salar, Carmen Burgaleta, Jose A. Queizán, Maria J. Peñarrubia, Maria D. Monteagudo, Carmen Cabrera, Javier De la Serna & José F. Tomás. (2009) Influence of MBL-2 mutations in the infection risk of patients with follicular lymphoma treated with rituximab, fludarabine, and cyclophosphamide. Leukemia & Lymphoma 50:8, pages 1283-1289.
Read now

Articles from other publishers (6)

Loretta J. Nastoupil, Peter McLaughlin, Lei Feng, Sattva S. Neelapu, Felipe Samaniego, Fredrick B. Hagemeister, Ana Ayala, Jorge E. Romaguera, Andre H. Goy, Eleanor Neal, Michael Wang, Luis Fayad, Michelle A. Fanale, Yasuhiro Oki, Jason R. Westin, Maria A. Rodriguez, Fernando Cabanillas & Nathan H. Fowler. (2017) High ten-year remission rates following rituximab, fludarabine, mitoxantrone and dexamethasone (R-FND) with interferon maintenance in indolent lymphoma: Results of a randomized Study. British Journal of Haematology 177:2, pages 263-270.
Crossref
Jae-Sook AhnDeok-Hwan YangSung-Hoon JungSoo-Young BaeHuong Thi Thanh TranHyung Chul ParkHa-Na KimYeo-Kyeoung KimHyeoung-Joon KimJe-Jung Lee. (2011) Fludarabine-containing chemotherapy for patients with previously untreated low-grade non-Hodgkin's lymphoma. The Korean Journal of Hematology 46:3, pages 180.
Crossref
Stefan Peinert, Dennis Carney, H. Miles Prince, E. Henry Januszewicz & John F. Seymour. (2009) Fludarabine combinations for patients with advanced marginal zone lymphomas - best treatment option or too toxic?. British Journal of Haematology 146:6, pages 685-686.
Crossref
Kun Yang, Jianlong Tan & Taixiang Wu. (2009) Alkylating agents for Waldenstrom's macroglobulinaemia. Cochrane Database of Systematic Reviews.
Crossref
Pier Luigi Zinzani, Monica Tani, Stefano Fanti, Vittorio Stefoni, Gerardo Musuraca, Umberto Vitolo, Alessio Perrotti, Mariapaola Fina, Enrico Derenzini & Michele Baccarani. (2008) A phase 2 trial of fludarabine and mitoxantrone chemotherapy followed by yttrium-90 ibritumomab tiuxetan for patients with previously untreated, indolent, nonfollicular, non-Hodgkin lymphoma. Cancer 112:4, pages 856-862.
Crossref
. (2005) Current Awareness in Hematological Oncology. Hematological Oncology 22:4, pages 183-190.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.